Cargando…
Characterization and metabolic synthetic lethal testing in a new model of SDH-loss familial pheochromocytoma and paraganglioma
Succinate dehydrogenase (SDH)-loss pheochromocytoma and paraganglioma (PPGL) are tumors driven by metabolic derangement. SDH loss leads to accumulation of intracellular succinate, which competitively inhibits dioxygenase enzymes, causing activation of pseudohypoxic signaling and hypermethylation of...
Autores principales: | Smestad, John, Hamidi, Oksana, Wang, Lin, Holte, Molly Nelson, Khazal, Fatimah Al, Erber, Luke, Chen, Yue, Maher, L. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814199/ https://www.ncbi.nlm.nih.gov/pubmed/29464059 http://dx.doi.org/10.18632/oncotarget.23639 |
Ejemplares similares
-
Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma
por: Hensen, Erik F., et al.
Publicado: (2010) -
Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications()()
por: Imperiale, Alessio, et al.
Publicado: (2015) -
Composite pheochromocytoma/paraganglioma-ganglioneuroma: analysis of SDH and ATRX status, and identification of frequent HRAS and BRAF mutations
por: Chen, Jingci, et al.
Publicado: (2021) -
Oxygen Concentration Controls Epigenetic Effects in Models of Familial Paraganglioma
por: Her, Yeng F., et al.
Publicado: (2015) -
OR34-6 A Novel Mechanism of SDH-Deficient Tumorigenesis and Implications for Genetic Testing in Patients with Pheochromocytoma-Paraganglioma
por: De Sousa, Sunita M.C., et al.
Publicado: (2019)